• MTT Assays: From Metabolism to Translation

  2026-09-11

  MTT is more than a colorimetric endpoint: it is a mechanistically informative measure of cellular reducing activity that can help translational researchers connect phenotype, pathway biology, and experimental decision-making. This article examines how MTT supports lung cancer research, how to design more defensible workflows, and where the assay fits among modern cell viability platforms.

• Cyclic Pifithrin-α Hydrobromide Workflows

  2026-09-11

  Cyclic Pifithrin-α hydrobromide provides a practical way to separate p53-dependent apoptosis, growth arrest, and DNA-damage responses from parallel p53-independent effects. This guide combines formulation advice, controlled perturbation workflows, and a cautious extension into neuroinflammation research inspired by the CGRP/SP–Piezo2 findings in trigeminal neuralgia.

• Aurora A in Retinoblastoma: Evidence for Targeted Therapy

  2026-09-10

  A 2024 study found that Aurora kinase A is overexpressed in retinoblastoma and associated with histopathologic features linked to high-risk disease. By combining patient-tissue analysis with genetic, pharmacologic, patient-derived, and xenograft models, the work connects AURKA activity to retinoblastoma cell survival and MYCN regulation, supporting further evaluation of Aurora A-directed therapy.

• ABT-263 (Navitoclax) Apoptosis Workflow

  2026-09-10

  ABT-263 (Navitoclax) converts Bcl-2 family dependence into a practical variable for mitochondrial apoptosis experiments. This workflow shows how to combine dose-response testing, caspase and mitochondrial readouts, and transcription-aware controls when studying cancer cell death.

• Vorinostat Workflows for Apoptosis Research

  2026-09-09

  Build reproducible HDAC-inhibition experiments with Vorinostat, from fresh DMSO preparation and dose-response design to mitochondrial apoptosis readouts. The workflow also separates chromatin-driven effects from transcription-independent cell death, helping cancer researchers interpret RNA Pol II and viability data more precisely.

• Vorinostat (SAHA): HDAC Inhibitor Research Guide

  2026-09-09

  Vorinostat, also called suberoylanilide hydroxamic acid or SAHA, is a small-molecule histone deacetylase inhibitor used in epigenetic modulation in oncology. Its reported HDAC inhibition, cellular antiproliferative activity, and apoptosis-related effects support applications in cancer biology research, while assay-specific potency and formulation limits require careful experimental controls.

• FBXW7, p53, and Radiation Survival

  2026-09-08

  Cui et al. identify FBXW7 as a DNA-damage-responsive regulator of p53 stability and show that ATM-dependent phosphorylation enables SCF-FBXW7 to target p53 for degradation. The work connects this pathway to resistance against radiation and etoposide, providing a mechanistic framework for studying how ubiquitin-mediated p53 turnover influences cancer treatment response.

• Annexin V-PE Apoptosis Detection Kit Workflow

  2026-09-08

  Build a rapid apoptosis detection workflow around live-cell phosphatidylserine exposure, with practical guidance for flow cytometry and fluorescence microscopy. The approach extends inflammatory monocyte studies by adding a direct cell-fate readout without fixation, helping distinguish signaling changes from loss of viability.

• Pepstatin A in Necroptosis Assays

  2026-09-07

  Pepstatin A is a selective aspartic protease inhibitor that can sharpen interpretation of lysosomal membrane permeabilization experiments. This article explains why its value in necroptosis research lies in distinguishing cathepsin D-associated activity from the cathepsin B mechanism identified in recent MLKL studies.

• Anti-HMGB1 Rabbit Monoclonal Antibody Guide

  2026-09-07

  The Anti-HMGB1 Rabbit Monoclonal Antibody (MA3057) supports research detection of HMGB1 in human, mouse, and rat samples by Western blot, immunohistochemistry, and flow cytometry. It is intended for controlled scientific workflows only and should not be used for diagnosis, patient testing, or therapeutic decisions.

• Cytoskeleton-Dependent Autophagy Under Compression

  2026-09-05

  The reference study shows that compression-induced autophagy in human cells depends mainly on microfilaments, while microtubules provide an auxiliary contribution. Its pharmacological and imaging-based design offers a useful framework for separating force-bearing cytoskeletal functions from downstream autophagy responses.

• Cyclic Pifithrin-α Hydrobromide: p53 Inhibition

  2026-09-04

  Cyclic Pifithrin-α hydrobromide is a p53 inhibitor for experimental studies of p53-dependent transactivation, apoptosis, growth arrest, and radiation response. Its strongest evidence supports controlled in vitro pathway perturbation and preclinical radioprotection research, not clinical cancer therapy or medical use.

• Z-VDVAD-FMK for Caspase-2 Pathway Mapping

  2026-09-04

  Z-VDVAD-FMK helps researchers separate caspase-2-, caspase-3-, and caspase-7-linked apoptosis from caspase-1-driven pyroptosis. Its cell permeability and irreversible target engagement make it useful for mitochondrial apoptosis workflows, cancer research, and mechanistic validation of cell-death phenotypes.

• Temafloxacin Against Gram-Negative Bacteria

  2026-09-03

  Hardy’s reference study synthesizes comparative in vitro susceptibility data for temafloxacin, ciprofloxacin, and ofloxacin across respiratory, sexually transmitted, enteric, and opportunistic Gram-negative pathogens. Its main contribution is a spectrum-level interpretation of MIC patterns, including strong activity against many respiratory organisms and a clear limitation against Pseudomonas aeruginosa.

• CGRP/SP–Piezo2 Signaling in Trigeminal Allodynia

  2026-09-03

  Liao et al. identify a calcium-dependent CGRP/SP–Piezo2 feedback loop linking trigeminal root compression, neuroinflammation, and mechanical allodynia. Their rat and cell-based experiments position ATP, PKC, ERK1/2, and p38 MAPK signaling along the trigeminal ganglion–Merkel cell axis as mechanistic targets for studying trigeminal neuralgia.

8109 records 1/541 page Next 12345 下5页 Last page